Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Datamonitors' Graceway Pharmaceuticals, LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Graceway Pharmaceuticals, LLC since January 2007.
– Provides intelligence on Graceway Pharmaceuticals, LLC's M&A, strategic partnerships and alliances, capital raising and private equity transactions. – Detailed reports of various financial transactions undertaken by Graceway Pharmaceuticals, LLC and its subsidiaries since 2007. – Information about key financial and legal advisors for Graceway Pharmaceuticals, LLC's financial deals transactions. – Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
This report includes Graceway Pharmaceuticals, LLC's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Graceway Pharmaceuticals, LLC. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Reasons to Purchase:
– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. – Form an independent opinion about Graceway Pharmaceuticals, LLC’s growth strategies through the organic and inorganic activities undertaken since 2007. – Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
Male Hypogonadism - Pipeline Review, H2 2019 Summary Pharmaceutical and Healthcare disease pipeline guide Male Hypogonadism - Pipeline Review, H2 2019, provides an overview of the Male Hypogonadism (Male Health) pipeline landscape. Male hypogonadism is a condition in which the body doesn’t...
Global Genitourinary Partnering 2014 to 2019 provides the full collection of Genitourinary disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Genitourinary partnering deals Financial deal terms for headline, upfront and royalty by stage of development Genitourinary...
The Global Regenerative Medicine Partnering 2014-2019: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into by the worlds...
Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H2 2019 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H2 2019, provides an overview of the Granulomatosis with Polyangiitis...
Achondroplasia - Pipeline Review, H2 2019 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Achondroplasia - Pipeline Review, H2 2019, provides an overview of the Achondroplasia (Musculoskeletal Disorders) pipeline landscape. Achondroplasia is a bone growth disorder that...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.